Pfizer 

ARS7.23
+ARS0+0% Friday 19:20

統計

當日最高
7.5
當日最低
7.2
52週最高
8.3
52週最低
6.47
成交量
2,831
平均成交量
1,893
市值
-
市盈率
-
股息收益率
5,752.62%
股息
415.91

即將到來

股息

5,752.62%股息收益率
10年增長
56.81%
5年增長率
62.54%
3年增長率
72.94%
1年增長率
79.02%

收益

4Feb預期
Q2 2024
Q3 2024
下一個
367.55
594.04
820.54
1,047.03
預期每股收益
479.9306157625
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 PFED.BA 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Show more...
首席執行官
Dr. Albert Bourla D.V.M., DVM, Ph.D.
員工
79000
國家
United States
ISIN
ARDEUT111424

上市公司